Time and resources are extremely valuable in biopharma manufacturing. Slow and inefficient manual workflows often lead to increased process variability, higher costs, and even product loss. To overcome these challenges, manufacturers are turning to directly integrated Process Analytical Technologies (PAT). PAT is a system that integrates real-time data acquisition and control into manufacturing processes. This approach supports Quality by Design, helping manufacturers build quality into products from the outset rather than relying solely on end-product testing.
Real-time data allows operators to detect deviations earlier, reduce process variability, and minimise batch failures. This inevitably leads to the overall improvement of manufacturing efficiency. Metrohm’s inline and online analytical solutions provide immediate insight into process performance, enabling faster corrective actions and more robust process control. As biopharma manufacturing becomes increasingly connected through digital technologies, industrial IoT, and advanced data analytics, PAT is expected to play a central role in enabling smarter, more predictive, and potentially autonomous manufacturing environments all whilst supporting regulatory compliance and consistent product quality.
